Related Articles
Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival
A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth
Patients with BRCA mutated ovarian cancer may have fewer circulating MDSC and more peripheral CD8+ T cells compared with women with BRCA wild‑type disease during the early disease course
LncRNAs KB‑1836B5, LINC00566 and FAM27L are associated with the survival time of patients with ovarian cancer
Molecular pathways associated with transcriptional alterations in hyperparathyroidism